Viewing Study NCT00807859


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2026-01-01 @ 3:34 AM
Study NCT ID: NCT00807859
Status: COMPLETED
Last Update Posted: 2022-11-08
First Post: 2008-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module